Regulatory impact statement
Publication Date:
14 December 2018
This regulatory impact statement examines the policy in relation to the personal import of medicines by the post/courier.
It was developed to supplement the previous regulatory impact statement Therapeutic Products Regulation – Replacement of the Medicines Act 1981 and the Medicines Regulations 1984 with a new legislative scheme for therapeutic products – Analysis of specific issues and options and should be considered within the context of the impacts outlined in it.